| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography, Prenatal | 150 | 2025 | 967 | 13.430 |
Why?
|
| Fetal Development | 30 | 2025 | 132 | 4.590 |
Why?
|
| Imaging, Three-Dimensional | 37 | 2025 | 372 | 3.980 |
Why?
|
| Fetal Heart | 27 | 2023 | 116 | 3.590 |
Why?
|
| Pregnancy | 193 | 2025 | 7193 | 3.450 |
Why?
|
| Fetal Weight | 11 | 2024 | 61 | 2.850 |
Why?
|
| Fetal Growth Retardation | 20 | 2024 | 239 | 2.540 |
Why?
|
| Gestational Age | 61 | 2025 | 1161 | 2.510 |
Why?
|
| Birth Weight | 14 | 2021 | 345 | 2.310 |
Why?
|
| Fetus | 19 | 2025 | 584 | 2.090 |
Why?
|
| Fetal Diseases | 22 | 2016 | 456 | 2.080 |
Why?
|
| Placenta | 14 | 2023 | 508 | 1.950 |
Why?
|
| Arm | 7 | 2024 | 81 | 1.840 |
Why?
|
| Thigh | 6 | 2016 | 51 | 1.670 |
Why?
|
| Body Composition | 10 | 2025 | 521 | 1.580 |
Why?
|
| Echocardiography, Four-Dimensional | 17 | 2014 | 18 | 1.500 |
Why?
|
| Pregnancy Trimester, Third | 22 | 2019 | 119 | 1.410 |
Why?
|
| Heart Ventricles | 5 | 2022 | 769 | 1.350 |
Why?
|
| Image Processing, Computer-Assisted | 15 | 2016 | 584 | 1.290 |
Why?
|
| Female | 198 | 2025 | 66722 | 1.260 |
Why?
|
| Infant, Small for Gestational Age | 9 | 2024 | 57 | 1.250 |
Why?
|
| Image Interpretation, Computer-Assisted | 14 | 2015 | 220 | 1.230 |
Why?
|
| Ultrasonography, Doppler | 5 | 2022 | 195 | 1.170 |
Why?
|
| Heart Defects, Congenital | 26 | 2023 | 1819 | 1.090 |
Why?
|
| Prenatal Diagnosis | 7 | 2017 | 596 | 1.080 |
Why?
|
| Prospective Studies | 34 | 2025 | 6153 | 1.020 |
Why?
|
| Infant, Newborn | 49 | 2025 | 8193 | 0.930 |
Why?
|
| Humans | 208 | 2025 | 125040 | 0.910 |
Why?
|
| Pregnancy Trimester, Second | 23 | 2023 | 165 | 0.870 |
Why?
|
| Obstetrics | 9 | 2022 | 237 | 0.870 |
Why?
|
| Echocardiography | 11 | 2023 | 1053 | 0.850 |
Why?
|
| Femur | 2 | 2017 | 66 | 0.840 |
Why?
|
| Ventricular Function, Left | 2 | 2016 | 509 | 0.800 |
Why?
|
| Reference Values | 15 | 2021 | 715 | 0.750 |
Why?
|
| Reproducibility of Results | 21 | 2021 | 2887 | 0.710 |
Why?
|
| Cardiac Output | 12 | 2012 | 171 | 0.700 |
Why?
|
| Fetal Macrosomia | 3 | 2018 | 20 | 0.690 |
Why?
|
| Biometry | 10 | 2024 | 136 | 0.690 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 7 | 2021 | 399 | 0.670 |
Why?
|
| Down Syndrome | 4 | 2010 | 198 | 0.650 |
Why?
|
| Pregnancy, Twin | 5 | 2025 | 180 | 0.620 |
Why?
|
| Microvessels | 1 | 2019 | 56 | 0.610 |
Why?
|
| Adult | 76 | 2025 | 29625 | 0.600 |
Why?
|
| Placenta Diseases | 1 | 2019 | 59 | 0.600 |
Why?
|
| Clinical Competence | 8 | 2022 | 1003 | 0.570 |
Why?
|
| Fetofetal Transfusion | 1 | 2020 | 194 | 0.570 |
Why?
|
| Sensitivity and Specificity | 22 | 2016 | 2053 | 0.560 |
Why?
|
| Placentation | 1 | 2017 | 55 | 0.560 |
Why?
|
| Ilium | 2 | 2010 | 23 | 0.520 |
Why?
|
| Echo-Planar Imaging | 1 | 2016 | 21 | 0.520 |
Why?
|
| Body Size | 2 | 2013 | 55 | 0.520 |
Why?
|
| Placenta Previa | 5 | 2023 | 65 | 0.510 |
Why?
|
| Cardiovascular Abnormalities | 3 | 2020 | 53 | 0.500 |
Why?
|
| Gadolinium | 1 | 2016 | 107 | 0.490 |
Why?
|
| Lung | 10 | 2024 | 1499 | 0.490 |
Why?
|
| Ventricular Function, Right | 1 | 2016 | 111 | 0.470 |
Why?
|
| Pregnancy Complications | 6 | 2025 | 512 | 0.470 |
Why?
|
| Myocardial Contraction | 1 | 2016 | 267 | 0.460 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 292 | 0.450 |
Why?
|
| Ventricular Function | 2 | 2012 | 91 | 0.440 |
Why?
|
| Ultrasonography, Doppler, Color | 5 | 2004 | 58 | 0.440 |
Why?
|
| Curriculum | 7 | 2022 | 726 | 0.440 |
Why?
|
| Hernia, Diaphragmatic | 3 | 2009 | 98 | 0.430 |
Why?
|
| Umbilical Arteries | 8 | 2022 | 98 | 0.420 |
Why?
|
| Uterus | 3 | 2016 | 569 | 0.420 |
Why?
|
| Pregnancy Complications, Infectious | 6 | 2018 | 455 | 0.420 |
Why?
|
| Pattern Recognition, Automated | 1 | 2013 | 49 | 0.410 |
Why?
|
| Neuroimaging | 1 | 2015 | 339 | 0.400 |
Why?
|
| Diaphragmatic Eventration | 2 | 2009 | 7 | 0.400 |
Why?
|
| Cohort Studies | 13 | 2024 | 4810 | 0.400 |
Why?
|
| Diabetes, Gestational | 3 | 2024 | 111 | 0.400 |
Why?
|
| Workflow | 1 | 2013 | 118 | 0.400 |
Why?
|
| Contrast Media | 1 | 2016 | 479 | 0.400 |
Why?
|
| Perinatology | 2 | 2022 | 32 | 0.390 |
Why?
|
| Cross-Sectional Studies | 13 | 2019 | 3421 | 0.390 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 873 | 0.390 |
Why?
|
| Workload | 1 | 2013 | 145 | 0.380 |
Why?
|
| Organ Size | 7 | 2025 | 436 | 0.380 |
Why?
|
| Internship and Residency | 5 | 2018 | 1181 | 0.370 |
Why?
|
| Pregnancy Trimester, First | 6 | 2018 | 114 | 0.370 |
Why?
|
| Nutrition Assessment | 1 | 2012 | 136 | 0.360 |
Why?
|
| Pregnancy Outcome | 10 | 2018 | 589 | 0.350 |
Why?
|
| Adiposity | 1 | 2012 | 190 | 0.350 |
Why?
|
| Extraembryonic Membranes | 3 | 2007 | 14 | 0.350 |
Why?
|
| Ultrasonography | 12 | 2022 | 940 | 0.350 |
Why?
|
| Retrospective Studies | 34 | 2024 | 16301 | 0.340 |
Why?
|
| Placenta Accreta | 4 | 2021 | 157 | 0.340 |
Why?
|
| Predictive Value of Tests | 12 | 2017 | 2165 | 0.330 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2014 | 142 | 0.330 |
Why?
|
| Stroke Volume | 11 | 2016 | 490 | 0.330 |
Why?
|
| Pelvis | 1 | 2010 | 71 | 0.320 |
Why?
|
| Adipose Tissue | 4 | 2018 | 466 | 0.320 |
Why?
|
| Malformations of Cortical Development | 1 | 2009 | 52 | 0.320 |
Why?
|
| Longitudinal Studies | 9 | 2018 | 1328 | 0.320 |
Why?
|
| Cerebral Cortex | 2 | 2009 | 452 | 0.320 |
Why?
|
| Algorithms | 8 | 2012 | 1629 | 0.310 |
Why?
|
| Prenatal Care | 5 | 2024 | 347 | 0.310 |
Why?
|
| Diaphragm | 1 | 2009 | 98 | 0.310 |
Why?
|
| Pulmonary Veins | 2 | 2010 | 161 | 0.300 |
Why?
|
| Texas | 8 | 2021 | 3586 | 0.300 |
Why?
|
| Amniotic Fluid | 5 | 2022 | 151 | 0.300 |
Why?
|
| Gynecology | 5 | 2018 | 123 | 0.300 |
Why?
|
| Ultrasonics | 3 | 2018 | 39 | 0.290 |
Why?
|
| Pregnancy, Ectopic | 2 | 2005 | 23 | 0.290 |
Why?
|
| National Institute of Child Health and Human Development (U.S.) | 2 | 2025 | 6 | 0.290 |
Why?
|
| Congenital Abnormalities | 3 | 2006 | 255 | 0.280 |
Why?
|
| Consensus | 2 | 2022 | 639 | 0.280 |
Why?
|
| Micrognathism | 3 | 2015 | 65 | 0.270 |
Why?
|
| Education, Medical, Graduate | 3 | 2022 | 517 | 0.270 |
Why?
|
| Pregnancy Complications, Cardiovascular | 4 | 2000 | 103 | 0.270 |
Why?
|
| Linear Models | 5 | 2012 | 680 | 0.270 |
Why?
|
| Nasal Bone | 2 | 2004 | 6 | 0.270 |
Why?
|
| Pregnancy Trimesters | 3 | 2018 | 34 | 0.260 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2021 | 3570 | 0.260 |
Why?
|
| Quality Assurance, Health Care | 2 | 2018 | 208 | 0.250 |
Why?
|
| Dandy-Walker Syndrome | 1 | 2005 | 11 | 0.240 |
Why?
|
| Hernia | 1 | 2005 | 19 | 0.240 |
Why?
|
| Chromosome Disorders | 2 | 2018 | 311 | 0.240 |
Why?
|
| Echocardiography, Three-Dimensional | 5 | 2009 | 53 | 0.240 |
Why?
|
| Observer Variation | 8 | 2014 | 298 | 0.240 |
Why?
|
| Pregnancy in Diabetics | 2 | 2012 | 19 | 0.240 |
Why?
|
| Spinal Dysraphism | 2 | 2015 | 270 | 0.240 |
Why?
|
| Twins | 1 | 2025 | 69 | 0.240 |
Why?
|
| Zika Virus Infection | 2 | 2018 | 171 | 0.240 |
Why?
|
| Placental Insufficiency | 2 | 2016 | 15 | 0.230 |
Why?
|
| Head | 3 | 2024 | 103 | 0.230 |
Why?
|
| Bed Rest | 1 | 2024 | 17 | 0.230 |
Why?
|
| Hemodynamics | 11 | 1991 | 852 | 0.220 |
Why?
|
| Liver Circulation | 1 | 2003 | 24 | 0.220 |
Why?
|
| Umbilical Cord | 2 | 2003 | 56 | 0.220 |
Why?
|
| Quality Improvement | 3 | 2018 | 640 | 0.210 |
Why?
|
| Obstetric Labor Complications | 2 | 2018 | 93 | 0.210 |
Why?
|
| Young Adult | 11 | 2025 | 9042 | 0.210 |
Why?
|
| Image Enhancement | 5 | 2012 | 163 | 0.210 |
Why?
|
| Anthropometry | 4 | 2009 | 197 | 0.210 |
Why?
|
| Plethysmography | 3 | 2012 | 35 | 0.200 |
Why?
|
| Male | 21 | 2018 | 61438 | 0.190 |
Why?
|
| United States | 13 | 2025 | 10904 | 0.190 |
Why?
|
| Hydrocephalus | 2 | 2021 | 242 | 0.180 |
Why?
|
| Rhombencephalon | 1 | 2021 | 46 | 0.180 |
Why?
|
| Growth Charts | 3 | 2018 | 15 | 0.180 |
Why?
|
| Cardiovascular System | 1 | 2022 | 106 | 0.180 |
Why?
|
| Medicine | 1 | 2022 | 98 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 5 | 2015 | 1266 | 0.180 |
Why?
|
| Blood Glucose | 2 | 2024 | 1133 | 0.180 |
Why?
|
| Gastroschisis | 1 | 2021 | 54 | 0.180 |
Why?
|
| Pilot Projects | 3 | 2020 | 1396 | 0.170 |
Why?
|
| Republic of Korea | 1 | 2020 | 37 | 0.170 |
Why?
|
| Diagnosis, Differential | 7 | 2015 | 1887 | 0.170 |
Why?
|
| Labor Presentation | 1 | 2000 | 10 | 0.170 |
Why?
|
| Vagina | 2 | 2018 | 189 | 0.170 |
Why?
|
| Stress, Psychological | 1 | 2025 | 558 | 0.170 |
Why?
|
| Cleft Lip | 2 | 2003 | 125 | 0.160 |
Why?
|
| Cleft Palate | 2 | 2003 | 140 | 0.160 |
Why?
|
| Pre-Eclampsia | 4 | 2010 | 221 | 0.160 |
Why?
|
| Feasibility Studies | 3 | 2018 | 759 | 0.160 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 2014 | 60 | 0.160 |
Why?
|
| Pleural Effusion | 2 | 2012 | 101 | 0.160 |
Why?
|
| Lung Volume Measurements | 3 | 2021 | 75 | 0.160 |
Why?
|
| Cervix Uteri | 3 | 2014 | 64 | 0.160 |
Why?
|
| Obstetric Labor, Premature | 3 | 2009 | 85 | 0.160 |
Why?
|
| Twins, Dizygotic | 1 | 2018 | 42 | 0.150 |
Why?
|
| Hysterectomy | 3 | 2021 | 186 | 0.150 |
Why?
|
| Cesarean Section | 4 | 2021 | 387 | 0.150 |
Why?
|
| Tachycardia | 1 | 2018 | 70 | 0.150 |
Why?
|
| Aging | 2 | 2016 | 1184 | 0.150 |
Why?
|
| Pelvic Floor Disorders | 1 | 2018 | 9 | 0.150 |
Why?
|
| Delivery, Obstetric | 5 | 2018 | 252 | 0.150 |
Why?
|
| Dilatation | 1 | 2018 | 66 | 0.140 |
Why?
|
| Transposition of Great Vessels | 4 | 2011 | 130 | 0.140 |
Why?
|
| Computer Simulation | 4 | 2014 | 651 | 0.140 |
Why?
|
| Lacerations | 1 | 2018 | 32 | 0.140 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2018 | 81 | 0.140 |
Why?
|
| User-Computer Interface | 2 | 2009 | 155 | 0.140 |
Why?
|
| Neural Tube Defects | 1 | 2021 | 356 | 0.140 |
Why?
|
| Shock, Septic | 2 | 1989 | 146 | 0.140 |
Why?
|
| Tomography | 2 | 2008 | 41 | 0.140 |
Why?
|
| Hypothermia, Induced | 1 | 2018 | 170 | 0.140 |
Why?
|
| Abdomen | 1 | 1997 | 127 | 0.140 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2016 | 18 | 0.140 |
Why?
|
| Cardiology | 1 | 2022 | 505 | 0.130 |
Why?
|
| Meglumine | 1 | 2016 | 14 | 0.130 |
Why?
|
| Epidemics | 1 | 2017 | 54 | 0.130 |
Why?
|
| Depression | 1 | 2025 | 1236 | 0.130 |
Why?
|
| Proteins | 2 | 2018 | 1036 | 0.130 |
Why?
|
| Pulmonary Artery | 5 | 2011 | 442 | 0.130 |
Why?
|
| Tensile Strength | 1 | 2016 | 40 | 0.130 |
Why?
|
| Energy Intake | 2 | 2018 | 493 | 0.130 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2017 | 63 | 0.130 |
Why?
|
| Elastic Modulus | 1 | 2016 | 28 | 0.130 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2016 | 81 | 0.130 |
Why?
|
| Immunoglobulin A | 3 | 2021 | 207 | 0.130 |
Why?
|
| Premature Birth | 2 | 2014 | 385 | 0.130 |
Why?
|
| Organometallic Compounds | 1 | 2016 | 109 | 0.130 |
Why?
|
| Chorioamnionitis | 2 | 2014 | 42 | 0.120 |
Why?
|
| Stress, Mechanical | 1 | 2016 | 173 | 0.120 |
Why?
|
| Systole | 1 | 2016 | 200 | 0.120 |
Why?
|
| Fast Foods | 1 | 2015 | 35 | 0.120 |
Why?
|
| Ductus Arteriosus | 2 | 2007 | 62 | 0.120 |
Why?
|
| Child Development | 1 | 2018 | 266 | 0.120 |
Why?
|
| Choroid Plexus | 2 | 2006 | 23 | 0.120 |
Why?
|
| Renal Veins | 1 | 2015 | 36 | 0.120 |
Why?
|
| Israel | 1 | 2015 | 45 | 0.120 |
Why?
|
| Commerce | 1 | 2015 | 50 | 0.120 |
Why?
|
| Pierre Robin Syndrome | 1 | 2015 | 30 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 18 | 3 | 2004 | 62 | 0.120 |
Why?
|
| Follow-Up Studies | 5 | 2023 | 5165 | 0.120 |
Why?
|
| Uterine Artery | 2 | 2016 | 29 | 0.120 |
Why?
|
| Placenta, Retained | 1 | 2014 | 12 | 0.120 |
Why?
|
| Food Supply | 1 | 2015 | 101 | 0.120 |
Why?
|
| Cerebrum | 1 | 2014 | 33 | 0.120 |
Why?
|
| alpha-Fetoproteins | 1 | 2015 | 132 | 0.110 |
Why?
|
| Computer-Assisted Instruction | 1 | 1995 | 51 | 0.110 |
Why?
|
| Cervical Length Measurement | 1 | 2014 | 5 | 0.110 |
Why?
|
| Trisomy | 3 | 2004 | 101 | 0.110 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 1994 | 30 | 0.110 |
Why?
|
| Encephalocele | 1 | 2014 | 51 | 0.110 |
Why?
|
| Aorta | 4 | 2011 | 547 | 0.110 |
Why?
|
| ROC Curve | 1 | 2016 | 569 | 0.110 |
Why?
|
| Clinical Protocols | 2 | 2014 | 239 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 1002 | 0.110 |
Why?
|
| Tetralogy of Fallot | 1 | 1995 | 163 | 0.110 |
Why?
|
| Frontal Lobe | 1 | 1994 | 116 | 0.110 |
Why?
|
| Oliguria | 3 | 1989 | 19 | 0.110 |
Why?
|
| Body Weights and Measures | 1 | 2013 | 42 | 0.110 |
Why?
|
| Vasa Previa | 1 | 2013 | 9 | 0.110 |
Why?
|
| Nanoparticles | 1 | 2016 | 232 | 0.110 |
Why?
|
| Erythrocyte Transfusion | 2 | 2014 | 129 | 0.110 |
Why?
|
| Energy Metabolism | 1 | 2018 | 767 | 0.110 |
Why?
|
| Fetal Blood | 1 | 1994 | 176 | 0.110 |
Why?
|
| Efficiency, Organizational | 1 | 2013 | 53 | 0.100 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 183 | 0.100 |
Why?
|
| Eclampsia | 3 | 1988 | 29 | 0.100 |
Why?
|
| Adrenal Gland Diseases | 1 | 1992 | 13 | 0.100 |
Why?
|
| Liver Diseases | 1 | 2016 | 365 | 0.100 |
Why?
|
| Genetic Testing | 1 | 2018 | 1002 | 0.100 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2014 | 170 | 0.100 |
Why?
|
| American Heart Association | 1 | 2014 | 322 | 0.100 |
Why?
|
| Diseases in Twins | 1 | 1992 | 94 | 0.090 |
Why?
|
| Time Factors | 3 | 2018 | 6327 | 0.090 |
Why?
|
| Fatal Outcome | 2 | 2010 | 356 | 0.090 |
Why?
|
| Ovary | 3 | 2005 | 380 | 0.090 |
Why?
|
| Aorta, Thoracic | 2 | 2007 | 531 | 0.090 |
Why?
|
| Infant, Premature | 2 | 2017 | 817 | 0.090 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 1991 | 28 | 0.090 |
Why?
|
| Models, Biological | 2 | 2014 | 1462 | 0.090 |
Why?
|
| Face | 1 | 2012 | 179 | 0.090 |
Why?
|
| Blood Component Removal | 1 | 1991 | 32 | 0.090 |
Why?
|
| Anuria | 2 | 1988 | 13 | 0.090 |
Why?
|
| Central Nervous System Diseases | 1 | 2011 | 107 | 0.090 |
Why?
|
| Myocardium | 1 | 2016 | 1021 | 0.090 |
Why?
|
| Typhoid Fever | 1 | 1990 | 19 | 0.080 |
Why?
|
| Population Groups | 1 | 2010 | 30 | 0.080 |
Why?
|
| Nutritional Status | 1 | 2012 | 314 | 0.080 |
Why?
|
| Term Birth | 1 | 2009 | 32 | 0.080 |
Why?
|
| Pulmonary Wedge Pressure | 4 | 1989 | 50 | 0.080 |
Why?
|
| Uterine Contraction | 1 | 1989 | 28 | 0.080 |
Why?
|
| Motion | 1 | 2009 | 43 | 0.080 |
Why?
|
| Prune Belly Syndrome | 1 | 2009 | 5 | 0.080 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2010 | 74 | 0.080 |
Why?
|
| Fellowships and Scholarships | 2 | 2022 | 280 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2014 | 495 | 0.080 |
Why?
|
| Michigan | 4 | 2013 | 42 | 0.080 |
Why?
|
| Hemorrhage | 1 | 1992 | 468 | 0.080 |
Why?
|
| Echocardiography, Doppler | 1 | 1989 | 171 | 0.080 |
Why?
|
| Puerperal Infection | 1 | 1988 | 7 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2011 | 1020 | 0.080 |
Why?
|
| Exercise | 5 | 2018 | 813 | 0.070 |
Why?
|
| Telemedicine | 1 | 2014 | 435 | 0.070 |
Why?
|
| Catheterization, Central Venous | 1 | 1989 | 131 | 0.070 |
Why?
|
| Lymphangioma, Cystic | 1 | 2008 | 16 | 0.070 |
Why?
|
| Data Display | 1 | 2007 | 12 | 0.070 |
Why?
|
| Cerebellum | 1 | 1991 | 415 | 0.070 |
Why?
|
| Mediastinal Neoplasms | 1 | 2008 | 42 | 0.070 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 1989 | 213 | 0.070 |
Why?
|
| Accreditation | 2 | 2018 | 88 | 0.070 |
Why?
|
| Pyelonephritis | 1 | 1987 | 26 | 0.070 |
Why?
|
| Postpartum Period | 5 | 2018 | 215 | 0.070 |
Why?
|
| Heart Rate | 7 | 1991 | 591 | 0.070 |
Why?
|
| Risk Factors | 7 | 2018 | 10280 | 0.070 |
Why?
|
| Anemia, Sickle Cell | 1 | 1991 | 331 | 0.070 |
Why?
|
| Pericardial Effusion | 1 | 2007 | 65 | 0.070 |
Why?
|
| Urinary Bladder | 1 | 2008 | 243 | 0.070 |
Why?
|
| Cleidocranial Dysplasia | 1 | 2006 | 6 | 0.070 |
Why?
|
| Blood Flow Velocity | 4 | 1994 | 457 | 0.070 |
Why?
|
| Vascular Malformations | 1 | 2007 | 88 | 0.070 |
Why?
|
| Brain | 1 | 2018 | 2999 | 0.060 |
Why?
|
| Pulmonary Circulation | 1 | 1986 | 121 | 0.060 |
Why?
|
| Individuality | 2 | 2017 | 34 | 0.060 |
Why?
|
| Stomach | 1 | 2008 | 272 | 0.060 |
Why?
|
| Genital Diseases, Female | 1 | 2005 | 28 | 0.060 |
Why?
|
| Hypophosphatasia | 1 | 2005 | 1 | 0.060 |
Why?
|
| Tooth Diseases | 1 | 2005 | 3 | 0.060 |
Why?
|
| Azygos Vein | 1 | 2005 | 8 | 0.060 |
Why?
|
| Heart Septal Defects | 1 | 2004 | 37 | 0.060 |
Why?
|
| Embryonic Development | 1 | 2006 | 214 | 0.060 |
Why?
|
| Vena Cava, Inferior | 1 | 2005 | 103 | 0.060 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2005 | 86 | 0.060 |
Why?
|
| Microcephaly | 2 | 2018 | 331 | 0.060 |
Why?
|
| Neck | 1 | 2005 | 135 | 0.060 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2006 | 205 | 0.060 |
Why?
|
| Glucose Intolerance | 1 | 2024 | 78 | 0.060 |
Why?
|
| Umbilical Veins | 1 | 2003 | 73 | 0.050 |
Why?
|
| Liver | 2 | 2024 | 1743 | 0.050 |
Why?
|
| Chromosome Aberrations | 2 | 2016 | 612 | 0.050 |
Why?
|
| Cysts | 1 | 2004 | 101 | 0.050 |
Why?
|
| Heart Valve Diseases | 1 | 2004 | 173 | 0.050 |
Why?
|
| Brain Diseases | 1 | 2006 | 298 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2005 | 362 | 0.050 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2005 | 728 | 0.050 |
Why?
|
| Sepsis | 1 | 1987 | 480 | 0.050 |
Why?
|
| Blood Circulation | 2 | 1994 | 21 | 0.050 |
Why?
|
| Models, Statistical | 2 | 2015 | 471 | 0.050 |
Why?
|
| Phenotype | 2 | 2009 | 4260 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 1987 | 560 | 0.050 |
Why?
|
| Data Collection | 1 | 2004 | 381 | 0.050 |
Why?
|
| Infant | 3 | 2022 | 12456 | 0.050 |
Why?
|
| Statistics as Topic | 2 | 2014 | 256 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 1095 | 0.050 |
Why?
|
| Bicycling | 2 | 1991 | 35 | 0.040 |
Why?
|
| Sphingomyelins | 1 | 1980 | 15 | 0.040 |
Why?
|
| Adolescent | 6 | 2018 | 19316 | 0.040 |
Why?
|
| Phosphatidylcholines | 1 | 1980 | 37 | 0.040 |
Why?
|
| Double Outlet Right Ventricle | 1 | 1999 | 21 | 0.040 |
Why?
|
| Functional Laterality | 1 | 2000 | 184 | 0.040 |
Why?
|
| Vascular Resistance | 5 | 1991 | 189 | 0.040 |
Why?
|
| Mice | 1 | 2016 | 17646 | 0.040 |
Why?
|
| Body Fluid Compartments | 1 | 2018 | 19 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2005 | 1638 | 0.040 |
Why?
|
| Body Water | 1 | 2018 | 90 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2021 | 302 | 0.040 |
Why?
|
| Education, Medical, Undergraduate | 1 | 1980 | 168 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2021 | 507 | 0.040 |
Why?
|
| Basal Metabolism | 1 | 2018 | 95 | 0.040 |
Why?
|
| Dextrocardia | 1 | 1998 | 9 | 0.040 |
Why?
|
| Indomethacin | 1 | 1978 | 84 | 0.040 |
Why?
|
| Luteinizing Hormone | 1 | 1978 | 131 | 0.040 |
Why?
|
| Subarachnoid Space | 1 | 2018 | 24 | 0.040 |
Why?
|
| Evoked Potentials, Visual | 1 | 2018 | 35 | 0.040 |
Why?
|
| Colombia | 1 | 2018 | 48 | 0.040 |
Why?
|
| Pelvic Floor | 1 | 2018 | 34 | 0.040 |
Why?
|
| Logistic Models | 1 | 2003 | 1809 | 0.040 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2018 | 66 | 0.040 |
Why?
|
| Perineum | 1 | 2018 | 47 | 0.040 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2018 | 53 | 0.040 |
Why?
|
| Cerebrospinal Fluid | 1 | 2018 | 93 | 0.040 |
Why?
|
| Nutritional Requirements | 1 | 2018 | 181 | 0.040 |
Why?
|
| Anal Canal | 1 | 2018 | 82 | 0.040 |
Why?
|
| Body Height | 1 | 2018 | 215 | 0.030 |
Why?
|
| Kidney | 1 | 2024 | 1368 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 1113 | 0.030 |
Why?
|
| Oxygen | 2 | 2018 | 555 | 0.030 |
Why?
|
| Calcinosis | 1 | 2018 | 179 | 0.030 |
Why?
|
| Wrist | 1 | 1996 | 24 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2002 | 959 | 0.030 |
Why?
|
| Reference Standards | 1 | 2017 | 236 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2008 | 112 | 0.030 |
Why?
|
| Animals | 2 | 2016 | 34246 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2018 | 12384 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 17 | 0.030 |
Why?
|
| Weight Gain | 1 | 2018 | 400 | 0.030 |
Why?
|
| Estradiol | 1 | 1978 | 532 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2018 | 313 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2018 | 277 | 0.030 |
Why?
|
| Environment Design | 1 | 2015 | 15 | 0.030 |
Why?
|
| Geographic Mapping | 1 | 2015 | 14 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2017 | 3297 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2015 | 89 | 0.030 |
Why?
|
| Oxygen Consumption | 3 | 1991 | 306 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2015 | 41 | 0.030 |
Why?
|
| Progesterone | 1 | 1978 | 623 | 0.030 |
Why?
|
| Glossoptosis | 1 | 2015 | 5 | 0.030 |
Why?
|
| Mothers | 1 | 2018 | 354 | 0.030 |
Why?
|
| Leg | 1 | 2016 | 158 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 462 | 0.030 |
Why?
|
| Libraries, Medical | 1 | 1995 | 4 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2015 | 81 | 0.030 |
Why?
|
| Crown-Rump Length | 1 | 2014 | 6 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2017 | 3452 | 0.030 |
Why?
|
| Polyhydramnios | 1 | 2015 | 56 | 0.030 |
Why?
|
| Prognosis | 2 | 2015 | 4627 | 0.030 |
Why?
|
| Models, Structural | 1 | 1994 | 50 | 0.030 |
Why?
|
| Brazil | 1 | 2014 | 122 | 0.030 |
Why?
|
| Interinstitutional Relations | 1 | 2014 | 20 | 0.030 |
Why?
|
| Pregnancy, High-Risk | 1 | 1994 | 43 | 0.030 |
Why?
|
| Italy | 1 | 2014 | 99 | 0.030 |
Why?
|
| Perinatal Mortality | 1 | 2014 | 43 | 0.030 |
Why?
|
| Disease Management | 1 | 2018 | 525 | 0.030 |
Why?
|
| Maternal Age | 1 | 1994 | 134 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2004 | 3727 | 0.030 |
Why?
|
| Hematocrit | 2 | 1991 | 111 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2014 | 153 | 0.030 |
Why?
|
| Blood Pressure | 5 | 1991 | 1370 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2007 | 779 | 0.030 |
Why?
|
| Research Design | 1 | 2017 | 694 | 0.030 |
Why?
|
| Radiology | 1 | 1995 | 106 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2015 | 278 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 219 | 0.030 |
Why?
|
| Arteries | 2 | 2011 | 224 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1994 | 980 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2018 | 1563 | 0.020 |
Why?
|
| Palate | 1 | 2012 | 13 | 0.020 |
Why?
|
| Precision Medicine | 1 | 2015 | 319 | 0.020 |
Why?
|
| Fluid Therapy | 2 | 1991 | 129 | 0.020 |
Why?
|
| Maxilla | 1 | 2012 | 36 | 0.020 |
Why?
|
| Educational Measurement | 1 | 1995 | 323 | 0.020 |
Why?
|
| Respiration | 1 | 1992 | 119 | 0.020 |
Why?
|
| Inservice Training | 1 | 2012 | 56 | 0.020 |
Why?
|
| Mandible | 1 | 2012 | 79 | 0.020 |
Why?
|
| Orbit | 1 | 2012 | 102 | 0.020 |
Why?
|
| Catheterization, Swan-Ganz | 2 | 1988 | 16 | 0.020 |
Why?
|
| Focus Groups | 1 | 2012 | 198 | 0.020 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 2 | 2003 | 78 | 0.020 |
Why?
|
| Hemoglobin A | 1 | 1991 | 22 | 0.020 |
Why?
|
| Plasma Volume | 1 | 1990 | 15 | 0.020 |
Why?
|
| Hemoglobin, Sickle | 1 | 1991 | 20 | 0.020 |
Why?
|
| Monitoring, Physiologic | 3 | 1990 | 377 | 0.020 |
Why?
|
| Anesthesia, Epidural | 1 | 1991 | 14 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 1991 | 77 | 0.020 |
Why?
|
| Hemoglobins | 2 | 2009 | 309 | 0.020 |
Why?
|
| Kidney Glomerulus | 1 | 1991 | 78 | 0.020 |
Why?
|
| Anesthesia, Obstetrical | 1 | 1991 | 33 | 0.020 |
Why?
|
| Survival Rate | 1 | 1995 | 2056 | 0.020 |
Why?
|
| Posture | 1 | 1991 | 154 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1990 | 124 | 0.020 |
Why?
|
| Physical Exertion | 1 | 1990 | 78 | 0.020 |
Why?
|
| Parity | 1 | 1990 | 78 | 0.020 |
Why?
|
| Physical Education and Training | 1 | 1990 | 20 | 0.020 |
Why?
|
| Salmonella typhi | 1 | 1990 | 16 | 0.020 |
Why?
|
| Nifedipine | 1 | 1989 | 21 | 0.020 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1990 | 93 | 0.020 |
Why?
|
| Mass Screening | 2 | 2011 | 784 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 2009 | 49 | 0.020 |
Why?
|
| Walking | 1 | 1991 | 212 | 0.020 |
Why?
|
| Puerperal Disorders | 1 | 1989 | 45 | 0.020 |
Why?
|
| Abdominal Wall | 1 | 2009 | 32 | 0.020 |
Why?
|
| Length of Stay | 1 | 2014 | 1307 | 0.020 |
Why?
|
| Hyperemesis Gravidarum | 1 | 1988 | 5 | 0.020 |
Why?
|
| Hyperthyroidism | 1 | 1988 | 25 | 0.020 |
Why?
|
| Thermodilution | 1 | 1988 | 11 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 439 | 0.020 |
Why?
|
| Eating | 1 | 1990 | 367 | 0.020 |
Why?
|
| Parietal Bone | 1 | 2007 | 10 | 0.020 |
Why?
|
| Mathematics | 1 | 2007 | 97 | 0.020 |
Why?
|
| Blood Pressure Determination | 1 | 1987 | 110 | 0.020 |
Why?
|
| Obesity | 1 | 2018 | 2247 | 0.020 |
Why?
|
| Dopamine | 1 | 1988 | 283 | 0.020 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1987 | 95 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2007 | 142 | 0.020 |
Why?
|
| Embolism, Amniotic Fluid | 1 | 1986 | 31 | 0.020 |
Why?
|
| Magnesium Sulfate | 1 | 1986 | 48 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 590 | 0.020 |
Why?
|
| Karyotyping | 1 | 2006 | 323 | 0.020 |
Why?
|
| Catheterization | 1 | 1986 | 236 | 0.010 |
Why?
|
| Bone Development | 1 | 2005 | 57 | 0.010 |
Why?
|
| Bone Diseases | 1 | 2005 | 44 | 0.010 |
Why?
|
| Intensive Care, Neonatal | 1 | 2005 | 53 | 0.010 |
Why?
|
| Tricuspid Valve | 1 | 2004 | 60 | 0.010 |
Why?
|
| Osteogenesis | 1 | 2004 | 154 | 0.010 |
Why?
|
| Critical Care | 1 | 1989 | 655 | 0.010 |
Why?
|
| Hand | 1 | 2004 | 100 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2006 | 534 | 0.010 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2005 | 150 | 0.010 |
Why?
|
| Diet | 1 | 1990 | 1140 | 0.010 |
Why?
|
| Radiography | 1 | 2005 | 820 | 0.010 |
Why?
|
| Medical Records | 1 | 2003 | 192 | 0.010 |
Why?
|
| Mitral Valve | 1 | 2004 | 249 | 0.010 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2006 | 344 | 0.010 |
Why?
|
| Fetal Death | 1 | 2003 | 112 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2005 | 694 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2004 | 369 | 0.010 |
Why?
|
| Seizures | 1 | 1986 | 870 | 0.010 |
Why?
|
| Oregon | 1 | 1980 | 9 | 0.010 |
Why?
|
| Child | 1 | 2021 | 24334 | 0.010 |
Why?
|
| Fetal Monitoring | 2 | 1990 | 56 | 0.010 |
Why?
|
| Hypertension | 1 | 1987 | 1330 | 0.010 |
Why?
|
| Prostaglandins | 1 | 1978 | 48 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1986 | 2099 | 0.010 |
Why?
|
| Incidence | 2 | 1996 | 3136 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1978 | 209 | 0.010 |
Why?
|
| Cholesterol | 2 | 1991 | 538 | 0.010 |
Why?
|
| Rabbits | 1 | 1978 | 718 | 0.010 |
Why?
|
| Ploidies | 1 | 1996 | 37 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 1996 | 49 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1999 | 333 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 26925 | 0.010 |
Why?
|
| Altitude | 1 | 1992 | 23 | 0.010 |
Why?
|
| Acid-Base Equilibrium | 1 | 1992 | 60 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1992 | 86 | 0.010 |
Why?
|
| Tidal Volume | 1 | 1991 | 38 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 1990 | 76 | 0.010 |
Why?
|
| Labor, Obstetric | 1 | 1991 | 94 | 0.010 |
Why?
|
| Heart Function Tests | 1 | 1990 | 57 | 0.010 |
Why?
|
| Postnatal Care | 1 | 1990 | 51 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 1990 | 21 | 0.010 |
Why?
|
| Anabolic Agents | 1 | 1990 | 14 | 0.010 |
Why?
|
| Pulse | 1 | 1989 | 29 | 0.010 |
Why?
|
| Blood Volume | 1 | 1990 | 81 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1991 | 278 | 0.010 |
Why?
|
| Lipoproteins, HDL | 1 | 1990 | 100 | 0.010 |
Why?
|
| Perception | 1 | 1991 | 220 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 1990 | 129 | 0.010 |
Why?
|
| Dietary Carbohydrates | 1 | 1990 | 119 | 0.000 |
Why?
|
| Counseling | 1 | 1990 | 218 | 0.000 |
Why?
|
| Fatty Acids | 1 | 1991 | 347 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1988 | 176 | 0.000 |
Why?
|
| Remission, Spontaneous | 1 | 1988 | 69 | 0.000 |
Why?
|
| Triglycerides | 1 | 1991 | 575 | 0.000 |
Why?
|
| Osmotic Pressure | 1 | 1988 | 22 | 0.000 |
Why?
|
| Dietary Proteins | 1 | 1990 | 251 | 0.000 |
Why?
|
| Sodium | 1 | 1988 | 297 | 0.000 |
Why?
|
| Body Weight | 1 | 1991 | 989 | 0.000 |
Why?
|
| Kidney Diseases | 1 | 1991 | 480 | 0.000 |
Why?
|
| Weight Loss | 1 | 1990 | 481 | 0.000 |
Why?
|
| Drug Resistance | 1 | 1986 | 257 | 0.000 |
Why?
|